<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31547454</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Deregulated <i>miR-29b-3p</i> Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1077</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells8091077</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is one of the most common incurable motor neuron disorders in adults. The majority of all ALS cases occur sporadically (sALS). Symptoms of ALS are caused by a progressive degeneration of motor neurons located in the motor cortex and spinal cord. The question arises why motor neurons selectively degenerate in ALS, while other cells and systems appear to be spared the disease. Members of the intrinsic apoptotic pathway are frequent targets of altered microRNA expression. Therefore, microRNAs and their effects on cell survival are subject of controversial debates. In this study, we investigated the expression of numerous members of the intrinsic apoptotic cascade by qPCR, western blot, and immunostaining in two different regions of the CNS of wobbler mice. Further we addressed the expression of <i>miR-29b-3p</i> targeting BMF, Bax, and, Bak, members of the apoptotic pathway. We show a tissue-specific differential expression of BMF, Bax, and cleaved-Caspase 3 in wobbler mice. An opposing regulation of <i>miR-29b-3p</i> expression in the cerebellum and cervical spinal cord of wobbler mice suggests different mechanisms regulating the intrinsic apoptotic pathway. Based on our findings, it could be speculated that <i>miR-29b-3p</i> might regulate antiapoptotic survival mechanisms in CNS areas that are not affected by neurodegeneration in the wobbler mouse ALS model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klatt</LastName><ForeName>Christina L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Ruhr University Bochum, Medical Faculty, Institute of Anatomy, Department of Cytology, 44801 Bochum, Germany. christinaklatt@online.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theis</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Ruhr University Bochum, Medical Faculty, Institute of Anatomy, Department of Cytology, 44801 Bochum, Germany. verena.theis@rub.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ruhr University Bochum, Clinical Research Center, Department of Molecular Gastrointestinal Oncology, 44801 Bochum, Germany. stephan.hahn@rub.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theiss</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ruhr University Bochum, Medical Faculty, Institute of Anatomy, Department of Cytology, 44801 Bochum, Germany. carsten.theiss@rub.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matschke</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9717-4485</Identifier><AffiliationInfo><Affiliation>Ruhr University Bochum, Medical Faculty, Institute of Anatomy, Department of Cytology, 44801 Bochum, Germany. Veronika.Matschke@rub.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494773">Bak1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C435486">Bmf protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C547014">MIRN29 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050998">bcl-2 Homologous Antagonist-Killer Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505409">Casp3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050998" MajorTopicYN="N">bcl-2 Homologous Antagonist-Killer Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">cerebellum</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword><Keyword MajorTopicYN="N">wobbler mouse</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31547454</ArticleId><ArticleId IdType="pmc">PMC6770833</ArticleId><ArticleId IdType="doi">10.3390/cells8091077</ArticleId><ArticleId IdType="pii">cells8091077</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shaw P., Eggett C. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J. Neurol. 2001;247:I17&#x2013;I27. doi: 10.1007/BF03161151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03161151</ArticleId><ArticleId IdType="pubmed">10795883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M., Ramirez A., Parente V., Simone C., Nizzardo M., Magri F., Dametti S., Corti S. Therapeutic development in amyotrophic lateral sclerosis. Clin. Ther. 2015;37:668&#x2013;680. doi: 10.1016/j.clinthera.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.12.020</ArticleId><ArticleId IdType="pubmed">25666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2012;3:CD001447. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S., Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) BBA-Mol. Basis Dis. 2015;1852:679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. New Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconer D.S. Wobbler (wr) Mouse News Lett. 1956;15:23.</Citation></Reference><Reference><Citation>Schmitt-John T., Drepper C., Mu&#xdf;mann A., Hahn P., Kuhlmann M., Thiel C., Hafner M., Lengeling A., Heimann P., Jones J.M., et al. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 2005;37:ng1661. doi: 10.1038/ng1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1661</ArticleId><ArticleId IdType="pubmed">16244655</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Victoria J.F., Abascal-Palacios G., Tasc&#xf3;n I., Kajava A., Magad&#xe1;n J.G., Pioro E.P., Bonifacino J.S., Hierro A. Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex. Proc. Natl. Acad. Sci. USA. 2010;107:12860&#x2013;12865. doi: 10.1073/pnas.1004756107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1004756107</ArticleId><ArticleId IdType="pmc">PMC2919957</ArticleId><ArticleId IdType="pubmed">20615984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs S., Resch K., Thiel C., Ulbrich M., Platzer M., Jockusch H., Schmitt-John T. Comparative transcription map of the wobbler critical region on mouse chromosome 11 and the homologous region on human chromosome 2p13-14. BMC Genet. 2002;3:40. doi: 10.1186/1471-2156-3-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2156-3-14</ArticleId><ArticleId IdType="pmc">PMC122058</ArticleId><ArticleId IdType="pubmed">12174196</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchen L., Strich S. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: The mutant &#x201c;wobbler&#x201d;. J. Neurol. Neurosurg. Psychiatry. 1968;31:535. doi: 10.1136/jnnp.31.6.535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.31.6.535</ArticleId><ArticleId IdType="pmc">PMC496420</ArticleId><ArticleId IdType="pubmed">5709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2001;27:723&#x2013;749. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Achi E.Y., Rudnicki S.A. ALS and frontotemporal dysfunction: A review. Neurol. Res. Int. 2012;2012:806306. doi: 10.1155/2012/806306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/806306</ArticleId><ArticleId IdType="pmc">PMC3423946</ArticleId><ArticleId IdType="pubmed">22919484</ArticleId></ArticleIdList></Reference><Reference><Citation>Heimann P., Laage S., Jockusch H. Defect of sperm assembly in a neurological mutant of the mouse, wobbler (WR) Differentiation. 1991;47:77&#x2013;83. doi: 10.1111/j.1432-0436.1991.tb00225.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-0436.1991.tb00225.x</ArticleId><ArticleId IdType="pubmed">1955109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2001;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis J.S. Citron Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein. Neuroscience. 2009;158:745&#x2013;750. doi: 10.1016/j.neuroscience.2008.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.10.030</ArticleId><ArticleId IdType="pubmed">19013502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Ferut A.L., Kurahashi K., McQuarrie I.G. Impairment of retrograde axonal transport in wobbler mouse motor neuron disease. Muscle Nerve. 1990;13:121&#x2013;126. doi: 10.1002/mus.880130206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880130206</ArticleId><ArticleId IdType="pubmed">2314413</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano R., Golfi P., Heimann P., Shaw C., Troakes C., Schmitt-John T., Bartsch J.W. Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: Implications for human motor neuron disease. BMC Neurosci. 2011;12:24. doi: 10.1186/1471-2202-12-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-12-24</ArticleId><ArticleId IdType="pmc">PMC3058068</ArticleId><ArticleId IdType="pubmed">21385376</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser J., Bigini P., Schmitt-John T. The wobbler mouse, an ALS animal model. Mol. Genet. Genomics. 2013;288:207&#x2013;229. doi: 10.1007/s00438-013-0741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-013-0741-0</ArticleId><ArticleId IdType="pmc">PMC3664746</ArticleId><ArticleId IdType="pubmed">23539154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D., Ceccarelli A., Dicuonzo F., Carella A., Caro D.M., Lopez M., Samarelli V., Livrea P., Simone I. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 2001;28:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu E., Agosta F., Riva N., Sala S., Prelle A., Caputo D., Perini M., Comi G., Filippi M. The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am. J. Neuroradiol. 2011;32:1307&#x2013;1314. doi: 10.3174/ajnr.A2469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2469</ArticleId><ArticleId IdType="pubmed">21680655</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., Xie S.X., Lee V., Trojanowski J.Q. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. (Chicago) 2008;65:636&#x2013;641. doi: 10.1001/archneur.65.5.636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.636</ArticleId><ArticleId IdType="pubmed">18474740</ArticleId></ArticleIdList></Reference><Reference><Citation>Troakes C., Maekawa S., Wijesekera L., Rogelj B., Sikl&#xf3;s L., Bell C., Smith B., Newhouse S., Vance C., Johnson L., et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology. 2012;32:505&#x2013;514. doi: 10.1111/j.1440-1789.2011.01286.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01286.x</ArticleId><ArticleId IdType="pubmed">22181065</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi D., Ott B., Dahlke C., Matschke V., Schmitt-John T., Theiss C. The spatiotemporal pattern of degeneration in the cerebellum of the wobbler mouse. J. Neuropath. Exp. Neur. 2016;75:347&#x2013;357. doi: 10.1093/jnen/nlw005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlw005</ArticleId><ArticleId IdType="pubmed">26945034</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Grosskreutz J. The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph. Lat. Scl. Fr. 2013;14:507&#x2013;515. doi: 10.3109/21678421.2013.812661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Henningsen H., Bremer J., Mock B., Deppe M., Buchinger C., Turski P., Knecht S., Brooks B. Pattern of cortical reorganization in amyotrophic lateral sclerosis: A functional magnetic resonance imaging study. Exp. Brain Res. 2002;143:51&#x2013;56. doi: 10.1007/s00221-001-0981-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-001-0981-9</ArticleId><ArticleId IdType="pubmed">11907690</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C., Jansen A., Henningsen H., Sommer J., Turski P., Brooks B., Knecht S. Subcortical reorganization in amyotrophic lateral sclerosis. Exp. Brain Res. 2006;172:361. doi: 10.1007/s00221-006-0352-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-006-0352-7</ArticleId><ArticleId IdType="pubmed">16463149</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld M., Tempelmann C., Gaul C., K&#xfc;hnel G., D&#xfc;zel E., Hopf J.-M., Feistner H., Zierz S., Heinze H.-J., Vielhaber S. Functional motor compensation in amyotrophic lateral sclerosis. J. Neurol. 2005;252:944&#x2013;952. doi: 10.1007/s00415-005-0787-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0787-y</ArticleId><ArticleId IdType="pubmed">15750701</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Valsasina P., Absinta M., Riva N., Sala S., Prelle A., Copetti M., Comola M., Comi G., Filippi M. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb. Cortex. 2011;21:2291&#x2013;2298. doi: 10.1093/cercor/bhr002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhr002</ArticleId><ArticleId IdType="pubmed">21368084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessitore A., Esposito F., Monsurr&#xf2; M.R., Graziano S., Panza D., Russo A., Migliaccio R., Conforti F.L., Morrone R., Quattrone A., et al. Subcortical motor plasticity in patients with sporadic ALS: An fMRI study. Brain Res. Bull. 2006;69:489&#x2013;494. doi: 10.1016/j.brainresbull.2006.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2006.01.013</ArticleId><ArticleId IdType="pubmed">16647577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A., Valentini M., Chi&#xf2; A., Nobili F., Calvo A., Moglia C., Montuschi A., Morbelli S., Salmaso D., Fania P., et al. Brain hypermetabolism in amyotrophic lateral sclerosis: A FDG PET study in ALS of spinal and bulbar onset. Eur. J. Nucl. Med. Mol. Imaging. 2012;39:251&#x2013;259. doi: 10.1007/s00259-011-1979-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-011-1979-6</ArticleId><ArticleId IdType="pubmed">22089661</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Peschanski M., Junier M.-P. The wobbler mouse. Mol. Neurobiol. 2003;28:65&#x2013;106. doi: 10.1385/MN:28:1:65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MN:28:1:65</ArticleId><ArticleId IdType="pubmed">14514986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott B., Dahlke C., Meller K., Napirei M., Schmitt-John T., Brand-Saberi B., Theiss C., Saberi D. Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment. Ann. Anat. 2015;200:118&#x2013;124. doi: 10.1016/j.aanat.2015.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aanat.2015.03.007</ArticleId><ArticleId IdType="pubmed">25929815</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 2000;7:613&#x2013;622. doi: 10.1006/nbdi.2000.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0314</ArticleId><ArticleId IdType="pubmed">11114260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohm M., May C., Marcus K., Steinbach S., Theis V., Theiss C., Matschke V. The microRNA miR-375-3p and the tumor suppressor NDRG2 are involved in sporadic amyotrophic lateral sclerosis. Cell. Physiol. Biochem. 2019;52:1412&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pubmed">31075191</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlke C., Saberi D., Ott B., Brand-Saberi B., Schmitt-John T., Theiss C. Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model. J. Neuroinflamm. 2015;12:215. doi: 10.1186/s12974-015-0435-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0435-0</ArticleId><ArticleId IdType="pmc">PMC4657283</ArticleId><ArticleId IdType="pubmed">26597538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. MicroRNAs genomics, biogenesis, mechanism, and function. Cell. 2004;116:281&#x2013;297. doi: 10.1016/S0092-8674(04)00045-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(04)00045-5</ArticleId><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. Metazoan microRNAs. Cell. 2018;173:20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman R.C., Farh K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92&#x2013;105. doi: 10.1101/gr.082701.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.082701.108</ArticleId><ArticleId IdType="pmc">PMC2612969</ArticleId><ArticleId IdType="pubmed">18955434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E., Gao F.-B. Cause or effect: Misregulation of microRNA pathways in neurodegeneration. Front. Neurosci. 2012;6:48. doi: 10.3389/fnins.2012.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2012.00048</ArticleId><ArticleId IdType="pmc">PMC3321503</ArticleId><ArticleId IdType="pubmed">22509148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollins S.L., Cairns M.J. MicroRNA: Small RNA mediators of the brains genomic response to environmental stress. Prog. Neurobiol. 2016;143:61&#x2013;81. doi: 10.1016/j.pneurobio.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.06.005</ArticleId><ArticleId IdType="pubmed">27317386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P., Rizzuti M., Faravelli I., Corti S. MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis. Mol. Neurobiol. 2018;55:2617&#x2013;2630. doi: 10.1007/s12035-017-0537-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0537-z</ArticleId><ArticleId IdType="pubmed">28421535</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., et al. Identification of miRNA changes in Alzheimer&#x2019;s disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimer&#x2019;s Dis. 2008;14:27&#x2013;41. doi: 10.3233/JAD-2008-14103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2008-14103</ArticleId><ArticleId IdType="pubmed">18525125</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe M., Bonini N.M. MicroRNAs and neurodegeneration: Role and impact. Trends Cell Biol. 2013;23:30&#x2013;36. doi: 10.1016/j.tcb.2012.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2012.08.013</ArticleId><ArticleId IdType="pmc">PMC3540990</ArticleId><ArticleId IdType="pubmed">23026030</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes O.C., Chertkow H.M., Wang E., Schipper H. MicroRNA: Implications for Alzheimer disease and other human CNS disorders. Curr. Genomics. 2009;10:154&#x2013;168. doi: 10.2174/138920209788185252.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920209788185252</ArticleId><ArticleId IdType="pmc">PMC2705849</ArticleId><ArticleId IdType="pubmed">19881909</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S.S., Horr&#xe9; K., Nicola&#xef; L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer&#x2019;s disease correlates with increased BACE1/&#x3b2;-secretase expression. Proc. Natl. Acad. Sci. USA. 2008;105:6415&#x2013;6420. doi: 10.1073/pnas.0710263105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0710263105</ArticleId><ArticleId IdType="pmc">PMC2359789</ArticleId><ArticleId IdType="pubmed">18434550</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S.S., Horr&#xe9; K., Nicola&#xef; L., Bergmans B., Papadopoulou A.S., Delacourte A., Strooper B. MicroRNA regulation of Alzheimer&#x2019;s Amyloid precursor protein expression. Neurobiol. Dis. 2009;33:422&#x2013;428. doi: 10.1016/j.nbd.2008.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.11.009</ArticleId><ArticleId IdType="pubmed">19110058</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan S., Kenny A., Medina M., Engel T., Jimenez-Mateos E.M. Chapter seven microRNAs in neurodegenerative diseases. Int. Rev. Cel. Mol. Bio. 2017;334:309&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">28838542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004;5:R13. doi: 10.1186/gb-2004-5-3-r13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2004-5-3-r13</ArticleId><ArticleId IdType="pmc">PMC395763</ArticleId><ArticleId IdType="pubmed">15003116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M., Filosa G., Melzi V., Calandriello L., Dioni L., Bollati V., Bresolin N., Comi G., Barabino S., Nizzardo M., et al. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci. Rep. 2018;8:10105. doi: 10.1038/s41598-018-28366-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28366-1</ArticleId><ArticleId IdType="pmc">PMC6031650</ArticleId><ArticleId IdType="pubmed">29973608</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.-F., Wu Z.-Y. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl. Neurodegener. 2016;5:3. doi: 10.1186/s40035-016-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-016-0050-8</ArticleId><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A., Eitan C., Liou L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A., et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS. Embo. J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Modigliani S., Torrelli G., Rosa A., Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. Embo. J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn S.J., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol. Cell Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS? Front. Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., Vanderweyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., et al. Correction: Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2011;6 doi: 10.1371/annotation/7d880410-06e3-4fe3-a8f1-e84c89bcf8d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/7d880410-06e3-4fe3-a8f1-e84c89bcf8d0</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., Vanderweyde T., Vanderwyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D., Comi G.P., Bresolin N., Corti S. MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis. J. Cell Mol. Med. 2019;23:1647&#x2013;1656. doi: 10.1111/jcmm.13976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13976</ArticleId><ArticleId IdType="pmc">PMC6378226</ArticleId><ArticleId IdType="pubmed">30614179</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi P., Jaiswal S., Sharma P. Regulation of neuronal cell cycle and apoptosis by microRNA 34a. Mol. Cell Biol. 2016;36:84&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702589</ArticleId><ArticleId IdType="pubmed">26459758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A., Namboori S.C., Bithell A., Soldati C., Buckley N.J., Stanton L.W. MiR-375 is essential for human spinal motor neuron development and may be involved in motor neuron degeneration. Stem Cells. 2016;34:124&#x2013;134. doi: 10.1002/stem.2233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2233</ArticleId><ArticleId IdType="pubmed">26507573</ArticleId></ArticleIdList></Reference><Reference><Citation>Santis R., Santini L., Colantoni A., Peruzzi G., de Turris V., Alfano V., Bozzoni I., Rosa A. FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Willimott S., Wagner S.D. miR-125b and miR-155 Contribute to BCL2 Repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells. J. Biol. Chem. 2012;287:2608&#x2013;2617. doi: 10.1074/jbc.M111.285718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.285718</ArticleId><ArticleId IdType="pmc">PMC3268420</ArticleId><ArticleId IdType="pubmed">22139839</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S., Bonanno S., Kapetis D., Barzago C., Cavalcante P., D&#x2019;Alessandro S., Mantegazza R., Bernasconi P. Upregulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage. Mol. Brain. 2015;8:5. doi: 10.1186/s13041-015-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0095-0</ArticleId><ArticleId IdType="pmc">PMC4318136</ArticleId><ArticleId IdType="pubmed">25626686</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.-H., Jang H., Lee I., Oh H., Choi E.-J., Rhim H., Kang S. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment. Hum. Mol. Genet. 2017;26:3615&#x2013;3629. doi: 10.1093/hmg/ddx250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx250</ArticleId><ArticleId IdType="pubmed">28666328</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Napoli G., Amadio S., Spalloni A., Apolloni S., Longone P., Volont&#xe9; C. MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ. 2016;23:531&#x2013;541. doi: 10.1038/cdd.2015.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.153</ArticleId><ArticleId IdType="pmc">PMC5072447</ArticleId><ArticleId IdType="pubmed">26794445</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmell J.C., Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002;109:S97&#x2013;S107. doi: 10.1016/S0092-8674(02)00704-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)00704-3</ArticleId><ArticleId IdType="pubmed">11983156</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal D., Kluck R., Dewson G. Building blocks of the apoptotic pore: How Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2014;21:196. doi: 10.1038/cdd.2013.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.139</ArticleId><ArticleId IdType="pmc">PMC3890949</ArticleId><ArticleId IdType="pubmed">24162660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay S., Panda P., Sinha N., Das D., Bhutia S. Autophagy and apoptosis: Where do they meet? Apoptosis. 2014;19:555&#x2013;566. doi: 10.1007/s10495-014-0967-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-014-0967-2</ArticleId><ArticleId IdType="pubmed">24415198</ArticleId></ArticleIdList></Reference><Reference><Citation>Oltval Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell. 1993;74:609&#x2013;619. doi: 10.1016/0092-8674(93)90509-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90509-O</ArticleId><ArticleId IdType="pubmed">8358790</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson E., Whitehead L., Adams R., Dewson G., Coultas L. Endothelial cell survival during angiogenesis requires the pro-survival protein MCL1. Cell Death Differ. 2016;23:1371. doi: 10.1038/cdd.2016.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2016.20</ArticleId><ArticleId IdType="pmc">PMC4947668</ArticleId><ArticleId IdType="pubmed">26943318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindqvist L.M., Heinlein M., Huang D.C., Vaux D.L. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc. Natl. Acad. Sci. USA. 2014;111:8512&#x2013;8517. doi: 10.1073/pnas.1406425111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1406425111</ArticleId><ArticleId IdType="pmc">PMC4060681</ArticleId><ArticleId IdType="pubmed">24912196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Koss B., Opferman J., Hildeman D. Mcl-1 antagonizes Bax/Bak to promote effector CD4+ and CD8+ T-cell responses. Cell Death Differ. 2013;20:998. doi: 10.1038/cdd.2013.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.25</ArticleId><ArticleId IdType="pmc">PMC3705594</ArticleId><ArticleId IdType="pubmed">23558951</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.-J., Zheng X.-P., Zhang R., Guo Y.-L., Wang J.-H. Combinatorial effects of miR-20a and miR-29b on neuronal apoptosis induced by spinal cord injury. Int. J. Clin. Exp. Patho. 2015;8:3811&#x2013;3818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4466950</ArticleId><ArticleId IdType="pubmed">26097563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Huang J., Ma Y., Tang G., Liu Y., Chen X., Zhang Z., Zeng L., Wang Y., Ouyang Y.-B., et al. MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4. J. Cereb. Blood F. Met. 2015;35:1977&#x2013;1984. doi: 10.1038/jcbfm.2015.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2015.156</ArticleId><ArticleId IdType="pmc">PMC4671118</ArticleId><ArticleId IdType="pubmed">26126866</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhter R., Saleem S., Saha A., Biswas S. The proapoptotic protein Bmf co-operates with Bim and Puma in neuron death induced by &#x3b2;-amyloid or NGF deprivation. Mol. Cell Neurosci. 2018;88:249&#x2013;257. doi: 10.1016/j.mcn.2018.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.02.011</ArticleId><ArticleId IdType="pubmed">29499358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardwick M.J., Soane L. Multiple functions of BCL-2 family proteins. Csh. Perspect. Biol. 2013;5:a008722. doi: 10.1101/cshperspect.a008722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a008722</ArticleId><ArticleId IdType="pmc">PMC3552500</ArticleId><ArticleId IdType="pubmed">23378584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwana T., Bouchier-Hayes L., Chipuk J.E., Bonzon C., Sullivan B.A., Green D.R., Newmeyer D.D. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell. 2005;17:525&#x2013;535. doi: 10.1016/j.molcel.2005.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.02.003</ArticleId><ArticleId IdType="pubmed">15721256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y.-T., Wolter K.G., Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-XL during&#x2009;apoptosis. Proc. Natl. Acad. Sci. USA. 1997;94:3668&#x2013;3672. doi: 10.1073/pnas.94.8.3668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.8.3668</ArticleId><ArticleId IdType="pmc">PMC20498</ArticleId><ArticleId IdType="pubmed">9108035</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur K., Whitehead L.W., Heddleston J.M., Li L., Padman B.S., Oorschot V., Geoghegan N.D., Chappaz S., Davidson S., Chin H., et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science. 2018;359:eaao6047. doi: 10.1126/science.aao6047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao6047</ArticleId><ArticleId IdType="pubmed">29472455</ArticleId></ArticleIdList></Reference><Reference><Citation>Buytaert E., Callewaert G., Vandenheede J., Agostinis P. Deficiency in apoptotic effectors BAX and BAK reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy. 2006;2:238&#x2013;240. doi: 10.4161/auto.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.2730</ArticleId><ArticleId IdType="pubmed">16874066</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z., Lu L., Jiang T., Zhang S., Shen Y., Zheng Z., Zhao A., Gao R., Li R., Zhou S., et al. miR-29b affects neurocyte apoptosis by targeting MCL-1 during cerebral ischemia/reperfusion injury. Exp. Ther. Med. 2018;16:3399&#x2013;3404. doi: 10.3892/etm.2018.6622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6622</ArticleId><ArticleId IdType="pmc">PMC6143871</ArticleId><ArticleId IdType="pubmed">30233687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., Huang D. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell. 2005;17:393&#x2013;403. doi: 10.1016/j.molcel.2004.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2004.12.030</ArticleId><ArticleId IdType="pubmed">15694340</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuconati A., Mukherjee C., Perez D., White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Gene Dev. 2003;17:2922&#x2013;2932. doi: 10.1101/gad.1156903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1156903</ArticleId><ArticleId IdType="pmc">PMC289151</ArticleId><ArticleId IdType="pubmed">14633975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kole A.J., Swahari V., Hammond S.M., Deshmukh M. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Gene Dev. 2011;25:125&#x2013;130. doi: 10.1101/gad.1975411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1975411</ArticleId><ArticleId IdType="pmc">PMC3022258</ArticleId><ArticleId IdType="pubmed">21245165</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;C T method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekegren T., Grundstr&#xf6;m E., Lindholm D., Aquilonius S.-M. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol. Scand. 1999;100:317&#x2013;321. doi: 10.1111/j.1600-0404.1999.tb00403.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00403.x</ArticleId><ArticleId IdType="pubmed">10536919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh N.P. Amyotrophic lateral sclerosis. Orphanet. J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Rouleau G.A., Ravits J., Cashman N.R. Clinical spectrum of amyotrophic lateral sclerosis (ALS) Csh. Perspect. Med. 2017;7:a024117. doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado M., Tesfaigzi Y. BH3-only proteins, Bmf and Bim, in autophagy. Cell Cycle. 2013;12:3453&#x2013;3454. doi: 10.4161/cc.26696.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.26696</ArticleId><ArticleId IdType="pmc">PMC3906325</ArticleId><ArticleId IdType="pubmed">24107625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockings C., Anwari K., Ninnis R., Brouwer J., O&#x2019;Hely M., Evangelista M., Hinds M., Czabotar P., Lee E., Fairlie W., et al. Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax. Cell Death Dis. 2015;6:e1735. doi: 10.1038/cddis.2015.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.105</ArticleId><ArticleId IdType="pmc">PMC4650538</ArticleId><ArticleId IdType="pubmed">25906158</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthalakath H., Villunger A., O&#x2019;Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E., Huang D.C., Strasser A. Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 2001;293:1829&#x2013;1832. doi: 10.1126/science.1062257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1062257</ArticleId><ArticleId IdType="pubmed">11546872</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmelzle T., Mailleux A.A., Overholtzer M., Carroll J.S., Solimini N.L., Lightcap E.S., Veiby O.P., Brugge J.S. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc. Natl. Acad. Sci. USA. 2007;104:3787&#x2013;3792. doi: 10.1073/pnas.0700115104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700115104</ArticleId><ArticleId IdType="pmc">PMC1820662</ArticleId><ArticleId IdType="pubmed">17360431</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann M., Leucht K., Ploner C., Kiessling S., Villunger A., Becker H., Hofmann C., Falk W., Krebs M., Kellermeier S., et al. BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells. J. Biol. Chem. 2011;286:26533&#x2013;26540. doi: 10.1074/jbc.M111.265322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.265322</ArticleId><ArticleId IdType="pmc">PMC3143618</ArticleId><ArticleId IdType="pubmed">21673109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramjaun A., Tomlinson S., Eddaoudi A., Downward J. Upregulation of two BH3-only proteins, Bmf and Bim, during TGF&#x3b2;-induced apoptosis. Oncogene. 2007;26:1209852. doi: 10.1038/sj.onc.1209852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209852</ArticleId><ArticleId IdType="pubmed">16909112</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau G.J., Godin N., Maachi H., Lo C.-S., Wu S.-J., Zhu J.-X., Brezniceanu M.-L., Ch&#xe9;nier I., Fragasso-Marquis J., Lattouf J.-B., et al. Bcl-2&#x2013;modifying factor induces renal proximal tubular cell apoptosis in diabetic mice. Diabetes. 2012;61:474&#x2013;484. doi: 10.2337/db11-0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-0141</ArticleId><ArticleId IdType="pmc">PMC3266424</ArticleId><ArticleId IdType="pubmed">22210314</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K., Adachi M., Kawamura R., Zhang Y. Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis. Cell Death Differ. 2005;13:129.</Citation><ArticleIdList><ArticleId IdType="pubmed">15947789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Adachi M., Kawamura R., Zou H., Imai K., Hareyama M., Shinomura Y. Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation. Apoptosis. 2006;11:1349&#x2013;1357. doi: 10.1007/s10495-006-8266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-8266-1</ArticleId><ArticleId IdType="pubmed">16830229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lossi L., Castagna C., Merighi A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci. 2018;19:3999. doi: 10.3390/ijms19123999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123999</ArticleId><ArticleId IdType="pmc">PMC6321612</ArticleId><ArticleId IdType="pubmed">30545052</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke P., Posada A., Primi M., Castagn&#xe9; V. Neuronal death in the central nervous system during development. Biomed. Pharmacother. 1998;52:356&#x2013;362. doi: 10.1016/S0753-3322(99)80002-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0753-3322(99)80002-X</ArticleId><ArticleId IdType="pubmed">9856281</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheim R., Flavell R., Vinsant S., Prevette D., Kuan C., Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. 2001;21:4752&#x2013;4760. doi: 10.1523/JNEUROSCI.21-13-04752.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-13-04752.2001</ArticleId><ArticleId IdType="pmc">PMC6762357</ArticleId><ArticleId IdType="pubmed">11425902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanjani H., Vogel M., Delhaye-Bouchaud N., Martinou J., Mariani J. Increased inferior olivary neuron and cerebellar granule cell numbers in transgenic mice overexpressing the human Bcl-2 gene. J. Neurobiol. 1997;32:502&#x2013;516. doi: 10.1002/(SICI)1097-4695(199705)32:5&lt;502::AID-NEU5&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4695(199705)32:5&lt;502::AID-NEU5&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">9110261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan D., Grooms S., Araneda R., Johnson A., Dobrenis K., Kessler J., Zukin R. AMPA receptor protein expression and function in astrocytes cultured from hippocampus. J. Neurosci. Res. 2001;57:557&#x2013;571. doi: 10.1002/(SICI)1097-4547(19990815)57:4&lt;557::AID-JNR16&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19990815)57:4&lt;557::AID-JNR16&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">10440906</ArticleId></ArticleIdList></Reference><Reference><Citation>Baader S.L., Sanlioglu S., Berrebi A.S., Parker-Thornburg J., Oberdick J. Ectopic overexpression of Engrailed-2 in cerebellar purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. J. Neurosci. 1998;18:1763&#x2013;1773. doi: 10.1523/JNEUROSCI.18-05-01763.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-05-01763.1998</ArticleId><ArticleId IdType="pmc">PMC6792618</ArticleId><ArticleId IdType="pubmed">9465001</ArticleId></ArticleIdList></Reference><Reference><Citation>Goswami J., Martin L.A., Goldowitz D., Beitz A.J., Feddersen R.M. Enhanced Purkinje cell survival but compromised cerebellar function in targeted antiapoptotic protein transgenic mice. Mol. Cell Neurosci. 2005;29:202&#x2013;221. doi: 10.1016/j.mcn.2005.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.02.010</ArticleId><ArticleId IdType="pubmed">15911345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowski J., Miething A., Schilling K., Oberdick J., Baader S. Cell death as a regulator of cerebellar histogenesis and compartmentation. Cerebellum. 2011;10:373&#x2013;392. doi: 10.1007/s12311-010-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-010-0222-5</ArticleId><ArticleId IdType="pubmed">20941559</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowski J., Miething A., Schilling K., Baader S.L. Physiological Purkinje cell death is spatiotemporally organized in the developing mouse cerebellum. Cerebellum. 2009;8:277&#x2013;290. doi: 10.1007/s12311-009-0093-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-009-0093-9</ArticleId><ArticleId IdType="pubmed">19238501</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung A., Kim T., Rhyu I., Kim H., Lee Y., Vinsant S., Oppenheim R.W., Sun W. Misplacement of Purkinje cells during postnatal development in Bax knock-out mice: A novel role for programmed cell death in the nervous system? J. Neurosci. 2008;28:2941&#x2013;2948. doi: 10.1523/JNEUROSCI.3897-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3897-07.2008</ArticleId><ArticleId IdType="pmc">PMC6670685</ArticleId><ArticleId IdType="pubmed">18337425</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckroth J.A., Goldowitz D., Eisenman L.M. Purkinje cell reduction in the reeler mutant mouse: A quantitative immunohistochemical study. J. Comp. Neurol. 1989;279:546&#x2013;555. doi: 10.1002/cne.902790404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.902790404</ArticleId><ArticleId IdType="pubmed">2918086</ArticleId></ArticleIdList></Reference><Reference><Citation>Croci L., Chung S.-H., Masserdotti G., Gianola S., Bizzoca A., Gennarini G., Corradi A., Rossi F., Hawkes R., Consalez G.G. A key role for the HLH transcription factor EBF2COE2,O/E-3 in Purkinje neuron migration and cerebellar cortical topography. Development. 2006;133:2719&#x2013;2729. doi: 10.1242/dev.02437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.02437</ArticleId><ArticleId IdType="pubmed">16774995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K., Kano M. Postnatal development and synapse elimination of climbing fiber to Purkinje cell projection in the cerebellum. Neurosci. Res. 2005;53:221&#x2013;228. doi: 10.1016/j.neures.2005.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2005.07.007</ArticleId><ArticleId IdType="pubmed">16139911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowrie M.B., Vrbov&#xe1; G. Dependence of postnatal motoneurones on their targets: Review and hypothesis. Trends Neurosci. 1992;15:80&#x2013;84. doi: 10.1016/0166-2236(92)90014-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(92)90014-Y</ArticleId><ArticleId IdType="pubmed">1373920</ArticleId></ArticleIdList></Reference><Reference><Citation>Herculano-Houzel S., Mota B., Lent R. Cellular scaling rules for rodent brains. Proc. Natl. Acad. Sci. USA. 2006;103:12138&#x2013;12143. doi: 10.1073/pnas.0604911103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0604911103</ArticleId><ArticleId IdType="pmc">PMC1567708</ArticleId><ArticleId IdType="pubmed">16880386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer S., Anilkumar U., Chen G., Ram&#xed;rez-Peinado S., Galindo-Moreno J., Mu&#xf1;oz-Pinedo C., Prehn J. Analysis of BH3-only proteins upregulated in response to oxygen/glucose deprivation in cortical neurons identifies Bmf but not Noxa as potential mediator of neuronal injury. Cell Death Dis. 2014;5:e1456. doi: 10.1038/cddis.2014.426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.426</ArticleId><ArticleId IdType="pmc">PMC4237251</ArticleId><ArticleId IdType="pubmed">25299781</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing X., Yang J., Jiang L., Chen J., Wang H. MicroRNA-29b regulates the mitochondria-dependent apoptotic pathway by targeting Bax in doxorubicin cardiotoxicity. Cell Physiol. Biochem. 2018;48:692&#x2013;704. doi: 10.1159/000491896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000491896</ArticleId><ArticleId IdType="pubmed">30025410</ArticleId></ArticleIdList></Reference><Reference><Citation>Czabotar P.E., Lessene G., Strasser A., Adams J.M. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat. Rev. Mol. Cell Bio. 2013;15:49&#x2013;63. doi: 10.1038/nrm3722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3722</ArticleId><ArticleId IdType="pubmed">24355989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang Y., Xu L., Lu Y., Sun X., Yue S., Xiong X., Giffard R.G. Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia. Glia. 2013;61:1784&#x2013;1794. doi: 10.1002/glia.22556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22556</ArticleId><ArticleId IdType="pmc">PMC3810393</ArticleId><ArticleId IdType="pubmed">24038396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang H.-W., Wentzel E.A., Mendell J.T. A Hexanucleotide element directs microRNA nuclear import. Science. 2007;315:97&#x2013;100. doi: 10.1126/science.1136235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1136235</ArticleId><ArticleId IdType="pubmed">17204650</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova L., Gr&#xe4;fe A., Seiler A., Schumacher S., Nitsch R., Wulczyn G.F. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 2005;21:1469&#x2013;1477. doi: 10.1111/j.1460-9568.2005.03978.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2005.03978.x</ArticleId><ArticleId IdType="pubmed">15845075</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-Y., Lee J., Ha M., Nam J.-W., Kim N.V. miR-29 miRNAs activate p53 by targeting p85&#x3b1; and CDC42. Nat. Struct. Mol. Bio. 2008;16:nsmb1533. doi: 10.1038/nsmb.1533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1533</ArticleId><ArticleId IdType="pubmed">19079265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J.J., Factora T.D., Dey S., Kota J. Systematic review of miR-29 in cancer. Mol Ther. 2018;12:173&#x2013;194. doi: 10.1016/j.omto.2018.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omto.2018.12.011</ArticleId><ArticleId IdType="pmc">PMC6369137</ArticleId><ArticleId IdType="pubmed">30788428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushing L., Kuang P., Qian J., Shao F., Wu J., Little F., Thannickal V.J., Cardoso W.V., L&#xfc; J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Resp. Cell Mol. 2011;45:287&#x2013;294. doi: 10.1165/rcmb.2010-0323OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2010-0323OC</ArticleId><ArticleId IdType="pmc">PMC3175558</ArticleId><ArticleId IdType="pubmed">20971881</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.-M., Jeong H.-J., Park S.-Y., Lee W. Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes. Febs. Lett. 2014;588:2170&#x2013;2176. doi: 10.1016/j.febslet.2014.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.05.011</ArticleId><ArticleId IdType="pubmed">24844433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Gong X., Han S., Zhang Y. MiR-29b protects dorsal root ganglia neurons from diabetic rat. Cell Biochem. Biophys. 2014;70:1105&#x2013;1111. doi: 10.1007/s12013-014-0029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-014-0029-y</ArticleId><ArticleId IdType="pubmed">24819309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauhari A., Singh T., Yadav S. Expression of miR-145 and its target proteins are regulated by miR-29b in differentiated neurons. Mol. Neurobiol. 2001;55:8978&#x2013;8990. doi: 10.1007/s12035-018-1009-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1009-9</ArticleId><ArticleId IdType="pubmed">29619741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugli G., Cohen A.M., Bennett D.A., Shah R.C., Fields C.J., Hernandez A.G., Smalheiser N.R. Plasma exosomal miRNAs in persons with and without Alzheimer disease: Altered expression and prospects for biomarkers. PLoS ONE. 2015;10:e0139233. doi: 10.1371/journal.pone.0139233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0139233</ArticleId><ArticleId IdType="pmc">PMC4591334</ArticleId><ArticleId IdType="pubmed">26426747</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J., Herl L.D., Farese R.V., Gao F.-B. MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia. PLoS ONE. 2010;5:e10551. doi: 10.1371/journal.pone.0010551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010551</ArticleId><ArticleId IdType="pmc">PMC2866661</ArticleId><ArticleId IdType="pubmed">20479936</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshan R., Shridhar S., Sarangdhar M.A., Banik A., Chawla M., Garg M., Singh V., Pillai B. Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice. RNA. 2014;20:1287&#x2013;1297. doi: 10.1261/rna.044008.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.044008.113</ArticleId><ArticleId IdType="pmc">PMC4105753</ArticleId><ArticleId IdType="pubmed">24958907</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou A.S., Serneels L., Achsel T., Mandemakers W., Callaerts-Vegh Z., Dooley J., Lau P., Ayoubi T., Radaelli E., Spinazzi M., et al. Deficiency of the miR-29a/b-1 cluster leads to ataxic features and cerebellar alterations in mice. Neurobiol. Dis. 2015;73:275&#x2013;288. doi: 10.1016/j.nbd.2014.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.10.006</ArticleId><ArticleId IdType="pubmed">25315682</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L., Zhang Y., Zhang S., Jiang T.-P., Chen L., Liu J., Zhou S. MicroRNA-29b alleviates oxygen and glucose deprivation/reperfusion-induced injury via inhibition of the p53-dependent apoptosis pathway in N2a neuroblastoma cells. Exp. Ther. Med. 2018;15:67&#x2013;74. doi: 10.3892/etm.2017.5410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.5410</ArticleId><ArticleId IdType="pmc">PMC5766061</ArticleId><ArticleId IdType="pubmed">29399057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R., Zhang R., Li H., Li H., Zhang S., Xie Y., Li S., Chen F. MiR-29 targets PUMA to suppress oxygen and glucose deprivation/reperfusion (OGD/R)-induced cell death in hippocampal neurons. Curr. Neurovasc. Res. 2018;15:47&#x2013;54. doi: 10.2174/1567202615666180403170902.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567202615666180403170902</ArticleId><ArticleId IdType="pubmed">29623838</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna S., Rink C., Ghoorkhanian R., Gnyawali S., Heigel M., Wijesinghe D.S., Chalfant C.E., Chan Y., Banerjee J., Huang Y., et al. Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J. Cereb. Blood F. Met. 2013;33:1197&#x2013;1206. doi: 10.1038/jcbfm.2013.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2013.68</ArticleId><ArticleId IdType="pmc">PMC3734770</ArticleId><ArticleId IdType="pubmed">23632968</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller-Carter P.I., Carter K.W., Anderson D., Harvey A.R., Giles K.M., Rodger J. Integrated analyses of zebrafish miRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration. BMC Genomics. 2015;16:591. doi: 10.1186/s12864-015-1772-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-015-1772-1</ArticleId><ArticleId IdType="pmc">PMC4534052</ArticleId><ArticleId IdType="pubmed">26265132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M., Lal A. MicroRNAs, wild-type and mutant p53: More questions than answers. RNA Biol. 2014;9:781&#x2013;791. doi: 10.4161/rna.20146.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.20146</ArticleId><ArticleId IdType="pmc">PMC3495745</ArticleId><ArticleId IdType="pubmed">22664917</ArticleId></ArticleIdList></Reference><Reference><Citation>Eve D.J., Dennis J.S., Citron B.A. Transcription factor p53 in degenerating spinal cords. Brain Res. 2007;1150:174&#x2013;181. doi: 10.1016/j.brainres.2007.02.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.02.088</ArticleId><ArticleId IdType="pubmed">17434459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Bowser R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol. J. 2010;4:11&#x2013;22. doi: 10.2174/1874375701004010011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874375701004010011</ArticleId><ArticleId IdType="pmc">PMC3092395</ArticleId><ArticleId IdType="pubmed">21572928</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan K., Walter F., Tuffy L.P., Poeschel S., Gallagher R., Haunsberger S., Bray I., Stallings R.L., Concannon C.G., Prehn J.H. Endoplasmic reticulum stress-mediated upregulation of miR-29a enhances sensitivity to neuronal apoptosis. Eur. J. Neurosci. 2016;43:640&#x2013;652. doi: 10.1111/ejn.13160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13160</ArticleId><ArticleId IdType="pubmed">26750440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K.-J., Deng Z., Huang H., Hamblin M., Xie C., Zhang J., Chen E.Y. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 2010;38:17&#x2013;26. doi: 10.1016/j.nbd.2009.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.12.021</ArticleId><ArticleId IdType="pmc">PMC2837803</ArticleId><ArticleId IdType="pubmed">20053374</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J., Xu L., Giffard R.G. Inhibition of microRNA-181 reduces forebrain ischemia-induced neuronal loss. J. Cereb. Blood F. Met. 2013;33:1976&#x2013;1982. doi: 10.1038/jcbfm.2013.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2013.157</ArticleId><ArticleId IdType="pmc">PMC3851907</ArticleId><ArticleId IdType="pubmed">24002437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripa R., Dolfi L., Terrigno M., Pandolfini L., Savino A., Arcucci V., Groth M., Tozzini E., Baumgart M., Cellerino A. MicroRNA miR-29 controls a compensatory response to limit neuronal iron accumulation during adult life and aging. BMC Biol. 2017;15:9. doi: 10.1186/s12915-017-0354-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-017-0354-x</ArticleId><ArticleId IdType="pmc">PMC5304403</ArticleId><ArticleId IdType="pubmed">28193224</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandi G., Nakka V.P., Dharap A., Roopra A., Vemuganti R. MicroRNA miR-29c downregulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage. PLoS ONE. 2013;8:e58039. doi: 10.1371/journal.pone.0058039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058039</ArticleId><ArticleId IdType="pmc">PMC3596316</ArticleId><ArticleId IdType="pubmed">23516428</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A.P., Wada S., Vergani L., Hock B.M., Lamon S., L&#xe9;ger B., Ushida T., Cartoni R., Wadley G.D., Hespel P., et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;49:107&#x2013;117. doi: 10.1016/j.nbd.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Catapano F., Domingos J., Perry M., Ricotti V., Phillips L., Servais L., Seferian A., de Groot I., Krom Y.D., Niks E.H., et al. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients. Epigenomics. 2018;10 doi: 10.2217/epi-2018-0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi-2018-0022</ArticleId><ArticleId IdType="pubmed">29564913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>